Paccar Inc (PCAR) concluded trading on Thursday at a closing price of $98.19, with 2.25 million shares of worth about $221.01 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.85% during that period and on March 27, 2025 the price saw a loss of about -1.35%. Currently the company’s common shares owned by public are about 524.40M shares, out of which, 515.43M shares are available for trading.
Stock saw a price change of -0.13% in past 5 days and over the past one month there was a price change of -7.39%. Year-to-date (YTD), PCAR shares are showing a performance of -5.60% which decreased to -18.14% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $87.53 but also hit the highest price of $122.00 during that period. The average intraday trading volume for Paccar Inc shares is 2.63 million. The stock is currently trading -3.78% below its 20-day simple moving average (SMA20), while that difference is down -6.94% for SMA50 and it goes to -4.17% lower than SMA200.
Paccar Inc (NASDAQ: PCAR) currently have 524.40M outstanding shares and institutions hold larger chunk of about 70.40% of that.
The stock has a current market capitalization of $51.54B and its 3Y-monthly beta is at 0.95. PE ratio of stock for trailing 12 months is 12.42, while it has posted earnings per share of $7.90 in the same period. It has Quick Ratio of 0.93 while making debt-to-equity ratio of 0.91. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PCAR, volatility over the week remained 1.42% while standing at 2.82% over the month.
Stock’s fiscal year EPS is expected to drop by -6.93% while it is estimated to increase by 17.34% in next year. EPS is likely to shrink at an annualized rate of -0.42% for next 5-years, compared to annual growth of 11.52% made by the stock over the past 5-years.
Coverage by UBS stated Paccar Inc (PCAR) stock as a Neutral in their note to investors on March 18, 2025, suggesting a price target of $108 for the stock. On January 14, 2025, BofA Securities Upgrade their recommendations, while on December 06, 2024, Jefferies Downgrade their ratings for the stock with a price target of $120. Stock get an Outperform rating from Evercore ISI on November 13, 2024.
